Emerging Growth Conference 79

February 18 & 19, 2025

Agenda Tuesday February 18, 2025

B.O.S. Better Online Solutions, Ltd. (NASDAQ: BOSC) integrates cutting-edge technologies to streamline and enhance supply chain operations across three specialized divisions: Intelligent Robotics, IFRD, and Supply Chain.

Keynote speaker: Eyal Cohen, President & CEO

Brenmiller Energy, Ltd. (NASDAQ: BNRG) helps energy-intensive industries and power producers end their reliance on fossil fuel boilers. Brenmiller’s patented bGen™ thermal battery is a modular and scalable energy storage system that turns renewable electricity into zero-emission heat. 

Keynote speaker: Nir Brenmiller, COO

Immuron Limited (NASDAQ: IMRN), is a  biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.

Keynote speaker: Steve Lydeamore, CEO

ASP Isotopes Inc. (NASDAQ: ASPI) is a pre-commercial stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries.

Keynote speaker: Paul Elliot Mann, CEO

U.S. Energy Corporation (NASDAQ: USEG) is a growth company focused on consolidating high-quality producing assets in the United States with the potential to optimize production and generate free cash flow through low-risk development while maintaining an attractive shareholder returns program. 

Keynote speaker: Ryan Smith, President, CEO & Director

Empire Energy (ASX: EEG) is a Sydney based Australian oil and gas company holding 100%-owned and operated assets with unconventional targets in the Northern Territory Beetaloo Sub-basin and central trough of the McArthur Basin.

Keynote speaker: Alex Underwood, CEO & Managing Director

Nova Minerals Limited (NASDAQ: NVA) (ASX: NVA) is a gold and critical minerals exploration and development company focused on advancing the Estelle Gold Project, comprised of 513 km2 of State of Alaska mining claims, which contains multiple mining complexes across a 35 km long mineralized corridor of over 20 identified gold prospects, including two already defined multi-million ounce resources across four deposits.

Keynote speaker: Christopher Gerteisen – CEO & Executive Director

Highland Copper Company Inc. (OTCQB: HDRSF) (TSXV: HI) is a Canadian company focused on exploring and developing copper projects in the Upper Peninsula of Michigan, U.S.A. 

Keynote speaker: Barry O’Shea, CEO

Collective Mining, Ltd. (NYSE American: CNL) (TSX: CNL) is a gold, silver, copper and tungsten exploration company with projects in Caldas, Colombia which was founded by the team that developed and sold Continental Gold Inc. to Zijin Mining for approximately $2 billion in enterprise value.

Keynote speaker: Ari Sussman, Executive Chairman

Ideal Power, Inc. (NASDAQ: IPWR) is the developer and innovative provider of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS/data center, solid-state circuit breaker and other industrial and military applications. 

Keynote speakers: Dan Brdar, President / CEO, and Tim Burns CFO

West Red Lake Gold Mines Ltd. (OTCQB: WRLGF) (TSXV: WRLG) is a mineral exploration company that is publicly traded and focused on advancing and developing its flagship Madsen Gold Mine and the associated 47 km2 highly prospective land package in the Red Lake district of Ontario.

Keynote Speaker: Gwen Preston, Vice President, Communications

Beneficient (NASDAQ: BENF) is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors and General Partners seeking exit options, anchor commitments and valued-added services for their funds with solutions that could help them unlock the value in their alternative assets.

Keynote speaker: Brad K. Heppner, CEO

Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain.

Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

Regen BioPharma Inc. (OTC Pink: RGBP) is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space.

Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

Agenda Wednesday February 19, 2025

Light.AI, Inc. (CBOE CA: ALGO) (FSE: 0HC) harnesses the power of assistive AI to revolutionize diagnostics, starting with infectious diseases like streptococcal pharyngitis.

Keynote speaker: Hugh Cleland, Director

Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs.

Keynote speaker: Stephen Anthony Stamp, CEO, CFO & Director

HydroGraph Clean Power Inc. (OTCQB: HGRAF) (CSE: HG) is a leading producer of pristine graphene using an “explosion synthesis” process, which allows for exceptional purity, low energy use and identical batches.

Keynote speaker: Kjirstin Breure, President and CEO

22nd Century Group, Inc. (NASDAQ: XXII) is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption.

Keynote speaker: Lawrence D. Firestone, Chairman & CEO

Aethlon Medical, Inc. (NASDAQ: AEMD) is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. 

Keynote speakers: Jim Frakes, Acting CEO and CFO & Steven LaRosa, Chief Medical Officer

Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension.

Keynote speaker: Bryan Giraudo, CFO & COO

Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. 

Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

ANGLE, plc. (OTCQX: ANPCY) (AIM: AGL) is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. 

Keynote speakers: Andrew David William Newland, Founder, CEO & Executive Director

Touchstone Explorations, Inc. (OTC Pink: PBEGF) (TSX: TXP) (LSE: TXP) is an innovative and dynamic company that engages in the complete exploration, development, and production lifecycle of oil and gas resources within onshore Trinidad.

Keynote speaker: Paul Raymond Baay President, CEO

Mesoblast, Ltd. (NASDAQ: MESO) is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. 

Keynote speakers: Dr. Silviu Itescu, Founder, CEO

GeoVax Labs, Inc. (NASDAQ: GOVX) is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers.

Keynote speakers: David Dodd, Chairman, President / CEO

Longeveron, Inc. (NASDAQ: LGVN) is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. 

Keynote speaker: Mohamed Wa’el Hashad, CEO & Director

U Power Limited (NASDAQ: UCAR) is a vehicle sourcing services provider, with a vision to becoming an EV market player primarily focused on its proprietary battery-swapping technology, or UOTTA technology, which is an intelligent modular battery-swapping technology designed to provide a comprehensive battery power solution for EVs. 

Keynote speaker: Paul Li, UCAR European Representative

Eloro Resources, Ltd. (OTCQX: ELRRF) (TSX: ELO) is an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

Keynote speakers: Thomas Larsen, CEO & Chairman, & Dr. William N. Pearson, Executive Vice President of Exploration

The Birch Co. (OTC Pink: ATWT) is at the forefront of the home construction industry, revolutionizing home construction with cutting-edge technology and affordable solutions.

Keynote speaker: Angus Martin, President & CEO

Sigyn Therapeutics, Inc. (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. The Company’s therapeutic candidates are each designed to overcome a clearly defined limitation in healthcare. 

Keynote speaker: James Allen Joyce, CEO

The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.

Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.

The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

Thank you for your interest in our conference, and we look forward to your participation in future conferences.